Uterine Cells Improved Ovarian Function in a Murine Model of Ovarian Insufficiency.
Ontology highlight
ABSTRACT: Primary ovarian insufficiency (POI) is defined as ovarian dysfunction in women younger than 40 years. It affects 1% of the women in this age-group and can occur iatrogenically after chemotherapy. Stem cells have been used in attempt to restore ovarian function in POI. In particular, endometrial mesenchymal stem cells (eMSCs) are easily obtainable in humans and have shown great potential for regenerative medicine. Here, we studied the potential for uterine cell (UC) suspensions containing eMSCs to improve ovarian function in a murine model of chemotherapy-induced POI. Green fluorescent protein (GFP)-labeled UC or phosphate-buffered solution (PBS) was delivered intravenously after chemotherapy. There was a significant increase in oocytes production and serum anti-Müllerian hormone concentrat
SUBMITTER: Reig A
PROVIDER: S-EPMC6949960 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA